First Comprehensive miRNA Landscape of Indian Endometrial Cancer
This pioneering study represents the first comprehensive NGS-based miRNA transcriptomic profiling of Indian endometrial cancer patients, aimed at decoding population-specific regulatory signatures associated with tumor progression and clinical outcome. Conducted by Dr. Bibha Choudhary and collaborators at IBAB, Bengaluru, the research integrated differential miRNA expression analysis, miRNA–mRNA interaction mapping, and comparative TCGA transcriptomic profiling to uncover clinically actionable non-coding RNA biomarkers.
The study identified novel and survival-associated miRNAs linked to disease heterogeneity, therapeutic response, and prognostic stratification, highlighting the emerging role of miRNA-driven regulatory networks in precision oncology and molecular classification of endometrial cancer.
Precision Oncology Significance
This landmark study presents the first NGS-based miRNA transcriptomic profiling of Indian endometrial cancer patients, uncovering population-specific non-coding RNA signatures linked to tumor progression, molecular heterogeneity, and patient survival. Integrative analysis of differentially expressed miRNAs and miRNA–mRNA interactions identified clinically relevant prognostic biomarkers with strong potential for precision oncology and molecular stratification.
miRNA Biomarker Discovery Workflow
Tumor Sample Collection → Small RNA Sequencing → miRNA Expression Profiling → Differential Expression Analysis → miRNA–mRNA Interaction Mapping → Prognostic Biomarker Discovery → Precision Oncology Insights
miRNA Sequencing Strategy
- NGS-based miRNA profiling of endometrial tumor samples
- Identification of differentially expressed & novel miRNAs
- Comparative analysis with TCGA global datasets
- Detection of prognostic miRNA–mRNA interactions
Integrative miRNA Analysis
- Differential miRNA expression analysis
- Survival-associated biomarker prioritization
- miRNA–mRNA interaction network mapping
- Cross-population transcriptomic comparison
Key Scientific Takeaway
Leveraging advanced NGS-based miRNA sequencing, transcriptomic intelligence, and AI-assisted biomarker analytics, Nucleome Informatics enabled deep characterization of population-specific endometrial cancer signatures in Indian patients. Through integrated identification of novel miRNAs, prognostic biomarkers, and miRNA–mRNA regulatory networks, Nucleome accelerated the translation of complex transcriptomic datasets into clinically actionable precision oncology insights.
With expertise spanning non-coding RNA biology, multi-omics integration, translational bioinformatics, and molecular diagnostics, Nucleome continues to empower large-scale cancer biomarker discovery programs focused on disease stratification, survival prediction, and personalized therapeutic decision-making.
Leave a Reply